Evaluation of bronchial constriction in children with cystic fibrosis after inhaling two different preparations of tobramycin

Chest

Volumn 122, Issue 3, 2002, Pages 930-934

  Alothman, Ghassan A ^a   Alsaadi, Muslim M ^a   Ho, Bernard L ^a   Ho, Sharon L ^a   Dupuis, Annie ^a   Corey, Mary ^a   Coates, Allan L ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Bronchial constriction; Bronchospasm; Cystic fibrosis; Inhaled antibiotics; Tobramycin

Indexed keywords

SALBUTAMOL; TOBRAMYCIN;

ADOLESCENT; ARTICLE; ASTHMA; BRONCHOSPASM; BRONCHUS HYPERREACTIVITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; CYSTIC FIBROSIS; DOUBLE BLIND PROCEDURE; DRUG FORMULATION; FEMALE; FORCED EXPIRATORY VOLUME; HIGH RISK POPULATION; HUMAN; MALE; MEDICAL ASSESSMENT; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD;

EID: 0036382644     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.122.3.930     Document Type: Article

References (20)

1. MacLusky IB, Gold R, Corey ML, et al. Long-term effects of inhaled tobramycin in patients with cystic fibrosis colonized with Pseudomonas aeruginosa. Pediatr Pulmonol 1989; 7:42-48
2. Steinkamp G, Tummler B, Gappa M, et al. Long-term tobramycin aerosol therapy in cystic fibrosis. Pediatr Pulmonol 1989; 6:91-98
3. Ramsey BW, Dorkin HL, Eisenberg JD, et al. Efficacy of aerosolized tobramycin in patients with cystic fibrosis. N Engl J Med 1993; 328:1740-1746
4. Ramsey BW, Pepe MS, Quan JF, et al. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. N Engl J Med 1999; 340:23-30
5. Mendelman PM, Smith AL, Levy J, et al. Aminoglycoside penetration, inactivation, and efficacy in cystic fibrosis sputum. Am Rev Respir Dis 1985; 132:761-765
6. Weisemann HG, Steinkamp G, Ratjen F, et al. Placebo-controlled, double-blind, randomized study of aerosolized tobramycin for early treatment of Pseudomonas aeruginosa colonization in cystic fibrosis. Pediatr Pulmonol 1998; 25:88-92
7. Nikolaizik WH, Jenni-Galovic V, Schöni MH. Bronchial constriction after nebulized tobramycin and saline in patients with cystic fibrosis [abstract]. Am J Respir Crit Care Med 1996; 153:A707
8. Chua HL, Collis GG, LeSouëf PN. Bronchial response to nebulized antibiotics in children with cystic fibrosis. Eur Respir J 1990; 3:1114-1116
9. Ramagopal M, Lands LC. Inhaled tobramycin and bronchial hyperreactivity in cystic fibrosis. Pediatr Pulmonol 2000; 29:366-370
10. Mellis CM, Levison H. Bronchial reactivity in cystic fibrosis. Pediatrics 1978; 61:446-450
11. Coates AL, MacNeish CF, Lands LC, et al. A comparison of the availability of tobramycin for inhalation from vented vs unvented nebulizers. Chest 1998; 113:951-956
12. Lung function testing: selection of reference values and interpretative strategies; American Thoracic Society. Am Rev Respir Dis 1991; 144:1202-1218
13. Standardization of spirometry, 1994 update: American Thoracic Society. Am J Respir Crit Care Med 1995; 152:1107-1136
14. Beasley R, Rafferty P, Holgate ST. Adverse reaction to the non-drug constituents of nebuliser solutions. Br J Clin Phar-macol 1988; 25:283-287
15. Nikolaizik WH, Jenni-Galovic V, Schöni MH. Bronchial constriction after nebulized tobramycin preparations and saline in patients with cystic fibrosis. Eur J Pediatr 1996; 155:608-611
16. Coates AL, MacNeish CF, Lands LC, et al. Factors influencing the rate of drug output during the course of wet nebulization. J Aerosol Med 1998; 11:101-111
17. Kwong E, MacNeish CF, Meisner D, et al. The use of osmometry as a means of determining changes in drug concentration during jet nebulization. J Aerosol Med 1998; 11:89-100
18. Boushey HA, Holtzman MJ, Sheller JR, et al. State of the art: bronchial hyperreactivity. Am Rev Respir Dis 1980; 121:389-413
19. Katz SL, Ho SL, Coates AL. Nebulizer choice for treatment of cystic fibrosis patients with inhaled colistin. Chest 2001; 119:250-255
20. Ho SL, Kwong WTJ, Coates AL. Evaluation of four breath-enhanced nebulizers for home use. J Aerosol Med 2001; 14:467-475